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Characteristics of Patients Initializing Peritoneal Dialysis 
Treatment From 2007 to 2014
Analysis From Henan Peritoneal Dialysis Registry data
Xiaoxue Zhang,1 Ying Chen,1,2 Yamei Cai,1 Xing Tian,1 Jing Xiao,1 
Zhanzheng Zhao,1 Dahai Yu1,2
Introduction. This study aimed to assess the number and profiles 
of patients initializing peritoneal dialysis form the Henan Peritoneal 
Dialysis Registry, a provincial database in central China.
Materials and Methods. All patients aged 18 years and greater, 
initializing peritoneal dialysis within the province during 2007 to 
2014 were included. Demographic characteristics were collected and 
clinical parameters included the type of renal diagnosis (primary 
glomerular, secondary glomerular, and others) and recorded 
major comorbidities in the neural, cardiovascular, respiratory, 
gastrointestinal, and endocrine systems. Laboratory measurements 
at treatment including blood urea nitrogen and creatinine were 
also determined. Differences, as a temporal trend over the period, 
were analyzed using a nonparametric test for trend across ordered 
groups.
Results. A total of 2540 patients were included. The number of 
patients increased rapidly by 8-fold from 2007 (n = 70) to 2014 
(n = 592). Overall, 40% were 55 years and older, and 60% were 
females. Forty-five percent of the patients were diagnosed with 
primary glomerular disease; 40%, secondary glomerular disease; 
and 15%, other kidney diseases. Half of the patients had comorbid 
conditions in cardiovascular system, followed by conditions in of the 
endocrine (15%) and neural (5%) systems. Over the study period, 
trends were in favor of more proportions of younger patients, 
female patients, and patients with secondary glomerular disease.
Conclusions. Peritoneal dialysis care increased rapidly in central 
region of China, with more younger and female patients over the 
study period.
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INTRODUCTION
The Chronic kidney disease has become an 
important public health issue worldwide and the 
mortality in patients with end-stage renal disease 
(ESRD) is more than 10-fold greater than general 
population worldwide, and even worse in the 
developing countries.1
The national survey in China estimated that 
about 120 million Chinese adults aged more than 18 
years had chronic kidney disease, and at some time 
point of their life, the dialysis might be needed.2 
In China, the population size of patients receiving 
dialysis increased rapidly over the past 2 decades;, 
only 41 755 patients were receiving dialysis by 1999, 
as compared with 102 863 patients by 2008, and 
258 000 patients by 2012.3,4 Although the patients 
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receiving hemodialysis incorporates the majority 
of patients receiving dialysis care, in recent years, 
peritoneal dialysis (PD) utilization increased even 
faster, as estimated more than 40 000 patients by 
2012.3 However, more PD facilities and trained 
nephrologists were located in the coastal regions 
and the capital of China, and provided PD care 
mainly to urban population.5 In the central China, 
where the majority of its population remained 
in rural area, the number and profile of patients 
receiving peritoneal care have not been well known.
The new rural cooperative medical insurance 
scheme in China was introduced in 2003 and 
started to sufficiently cover rural population in 
Henan province since 2008,6 which facilitated 
PD as an affordable treatment option for rural 
patients. Henan is the third largest province in 
China regarding to the size of population (94 
million people; female, 49.5%; China Census 
2010),7 with 60% of its population living in rural 
area, a representative region for the central China. 
The objective of the current study was to assess 
the number and profile of the whole provincially 
corded patients initializing PD care in Henan from 
2007 to 2014.
MATERIALS AND METHODS
Data Source
The Henan Peritoneal Dialysis Registry (HPDR) 
is operated under the auspices of the Department 
of Nephrology, the First Affiliated Hospital of 
Zhengzhou University and provides independent 
audit  and analysis  of  renal  care in Henan, 
China. Information was prospectively collected 
electronically from all renal units across Henan 
province. Data received at HPDR are subjected 
to algorithm which identifies suspicious values. 
If suspicious data is caught further verification 
will be carried out manually by contacting the 
relevant renal unit, and any correction will be 
made wherever necessary. The registration officially 
launched in 2007 and in this analysis all patients 
aged more than 18 years and initializing PD within 
the province between 2007 and 2014 were included. 
The data for hemodialysis was not included in the 
current study.
Measurements
Sex and age (grouped into 5 categories of < 35, 
35 to 44, 45 to 54, 55 to 64, and ≥ 65 years old) 
and body mass index (BMI, kg/m2) at the first time 
of PD treatment were collected as demographic 
characteristics. Clinical parameters included type of 
diagnosed kidney disease (ie, primary glomerular 
disease, secondary glomerular disease, other kidney 
diseases) and recorded major comorbid conditions in 
neural, cardiovascular, respiratory, gastrointestinal, 
and endocrine systems. Laboratory measurements 
were those collected during the episode of PD 
treatment at clinics using standard methods. Blood 
urea nitrogen (mmol/L) and creatinine (µmol/L) 
were included.
Ethics and Consent
Ethics approval was granted by the Clinical 
Research Ethics Committee of the First Affiliated 
Hospital of Zhengzhou University. Written informed 
consent was obtained from all participants at 
registration.
Statistical Analysis
The demographic, clinical, and laboratory 
characteristics of the patients initializing PD were 
described as a whole and by each calendar year 
using standard descriptive statistics. Difference 
as a temporal trend over the study period (2007 
to 2014) was analyzed by a nonparametric test for 
trend across ordered groups, an extension of the 
Wilcoxon rank-sum test.8 There was missing data 
on measurements of BMI, blood urea nitrogen, 
and creatinine. The demographics (age and sex) in 
patients with complete and incomplete data were 
compared using the Chi-squared test. The statistical 
significant level was set at a P value less than .05, 
two tailed. All statistical analyses were carried out 
using the Stata (version 14.0, StataCorp LP, College 
Station, TX, USA). Graphics were produced using 
the Microsoft Excel 2010.
RESULTS
In total, 2540 patients were recorded. The number 
of patients initializing PD increased rapidly from 
2007 to 2012 (an approximate 8-fold increase), and 
then remained approximately stable during the 
recent years (Table 1). Collected demographic, 
clinical, and laboratory parameters in all patients 
between 2007 and 2014 are summarized in Table 2. 
Approximately 40% of the patients were 55 years 
old and over, and 60% were females. Forty-five 
percent of the patients were diagnosed with primary 
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glomerular disease; 40%, secondary glomerular 
disease; and the remaining 15%, as other kidney 
diseases. Half of the patients had comorbid 
conditions related to the cardiovascular system, 
followed by comorbidities in the endocrine (15%) 
and neural (5%) systems.
By calendar year, more proportion of the patients 
aged less than 35 years old (from 5.7% in 2007 to 
16.7% in 2014) and less proportion aged 65 years and 
greater (from 28.5% in 2007 to 16.2% in 2014) were 
observed, showing a decreasing trend in patients’ 
age over the study period (P = .004; Figure 1). In 
2007, 45.7% of the patients were females, while this 
increased to 62.2% in 2014 (P = .001; Figure 1). No 
difference was observed in BMI (Figure 1).
The percentage of patients diagnosed with 
different kidney diseases, stratified by calendar 
year is shown in Figure 2. Except for the data in 
2007, during the earlier years (2008 to 2011), there 
was a higher proportion of patients with a primary 
glomerular disease compared to the proportion 
with a secondary glomerular disease. However, 
the difference became smaller as the time went 
ahead. In the recent years (2012 to 2014), primary 
and secondary glomerular diseases contributed 
approximately equally (each about 40%) to the 
patient population. During all the study years, 
testing for trend suggested an increased contribution 
from secondary glomerular disease (P < .001). The 
record of major comorbid conditions stratified by 
calendar year is presented in Figure 3.
The assessment of levels of blood urea nitrogen 
and creatinine demonstrated no significant difference 
over the study period (Figure 4). The age and sex 
in the patients with complete and incomplete data 
were shown in Table 3. No significant difference 
was found in the demographics between the two 
groups.
DISCUSSION
To our knowledge, this is the first study that 
investigated the number and profile of patients 
initializing PD care in a central region of China 
where rural residents contribute to the majority 
of population and during the years when the new 
rural cooperative medical insurance scheme was 
introduced.
The results show that patients initializing PD 
increased rapidly from 2007 to 2014, according 
to the provincial registration database of Henan. 
Higher proportion of younger and female patients 
was observed in the recent years, compared to that 
in the earlier period. Secondary glomerular disease 
was shown to become a more important disease for 
which patients initializing PD treatment over the 
study period in contrast with primary glomerular 
disease, despite of the rapidly increasing number 
of PD care for both diseases. However, the reason 
behind such changes remains to be investigated. 
Some laboratory markers measuring kidney 
Study Year Number of Patients
2007 70
2008 84
2009 150
2010 146
2011 353
2012 549
2013 596
2014 592
Table 1. Number of Patients Initializing Peritoneal Dialysis by 
Calendar Year
Characteristic Value
Demographic
Number of patients 2540
Age, y
< 35 371 (14.6)
35 to 44 518 (20.4)
45 to 54 641 (25.2)
55 to 64 567 (22.3)
≥ 65 443 (17.4)
Females 1491 (58.7)
Body mass index, kg/m2 23.0 (21.0 to 25.0)†
Clinical
Diagnosis
Primary glomerular disease 1132 (44.6)
Secondary glomerular disease 1013 (39.9)
Other renal disease 395 (15.5)
Comorbidity in neural system 130 (5.1)
Comorbidity in cardiovascular 
system
1260 (49.6)
Comorbidity in respiratory system 61 (2.4)
Comorbidity in gastrointestinal 
system
100 (3.9)
Comorbidity in endocrine system 391 (15.4)
Laboratory
Median blood urea nitrogen, mmol/L 21.9 (17.7 to 26.5)†
Median serum creatinine, µmol/L 871.0 (668.1 to 1085.0)†
Table 2. Characteristics of All Patients Initialising Peritoneal 
Dialysis*
*Values are frequencies (percentage) or median (interquartile range).
†Body mass index on 1447 patients (57.0%); blood urea nitrogen 
on 1440 patients (55.1%); and serum creatinine on 1402 patients 
(55.2%).
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Figure 1. Patient demographics (age, sex, and body mass index) by calendar year (2007 to 2014).
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function, which included blood urea nitrogen and 
creatinine, suggest that patients’ kidney function 
at the baseline of receiving PD care did not differ 
over the study period.
Although no trend data on the prevalence of 
chronic kidney disease over the relevant years 
was reported in China, several studies in other 
countries showed a stable trend.9,10 According to 
a population-based screening study on residents 
over 40 years old in Henan province in 2010, 
approximately 10.5% of the subjects had an indicator 
of kidney damage.12 There was therefore a large 
size of potential patients who needed dialysis in 
Henan. In the current study, an 8-fold increase in 
the number of patients starting PD care was seen 
from 2007 to 2014. The beginning point coincided 
with the start of sufficient coverage of medical 
insurance under the new rural cooperative scheme, 
suggesting this increasing trend may be driven by 
financial affordability rather than disease burden. 
Improved family income might also contribute to 
the increasing trend. However, no information 
was available from HPDR. It was reported that 
16% of Chinese patients withdrew from dialysis 
due to financial stress in 1999.3 Our study implied 
somehow there might be some proportion of patients 
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Figure 2. Percentage of patients diagnosed with primary glomerular, secondary glomerular, and other renal diseases by calendar year 
(2007 to 2014).
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Figure 3. Percentage of patients identified with comorbid conditions in major systems by calendar year (2007 to 2014).
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decided not to receive dialysis treatment due to 
financial burden. However, data for hemodialysis 
was not included in the current study.
Long-term dialysis is life-saving for patients with 
end stage renal disease.12 Those residing within 
the east and large city centers have greater access 
to affordable healthcare, while those living within 
the remote areas tend to be less able to afford or 
access chronic dialysis or healthcare. Although it 
has been largely improved during the last decade, 
greater effort is required to support to deliver 
sustainable PD care to uremic patients living in 
rural China.
There were several limitations in our study. First, 
although the majority of population in Henan is 
rural residents, the actual background (ie, rural 
or urban) of patients in the current study was not 
assessed. Second, residents in Henan may receive 
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Figure 4. Laboratory measurement (blood urea nitrogen and creatinine) of patients initializing peritoneal dialysis by calendar year (2007 
to 2014).
Characteristics
Patients With 
Complete Data
(n = 1387)
Patients With 
Incomplete Data
(n = 1153)
P
Age, y
< 35 219 (15.8) 152 (13.2)
35 to 44 281 (20.3) 237 (20.6)
45 to 54 355 (25.6) 286 (24.8)
55 to 64 303 (21.9) 264 (22.9)
≥ 65 229 (16.5) 214 (18.6) > .05
Females 811 (58.5) 680 (59.0) > .05
Table 3. Age and Sex Distributions in Patients With Complete 
and Incomplete Data
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PD care in other provinces. However, due to the 
restricted term on the medical insurance scheme (ie, 
insurance coverage only applies to the cost spent 
within the province), only a very small proportion 
if not none is expected. Third, although the clinical 
measurements were validated by the algorithm, 
the report of comorbid condition from renal clinics 
was not further validated by the registration 
center. Fourth, it cannot be ruled out that the 
quality of recording in HPDR went better along 
with the time, so the data might be biased by this 
possibility. Fifth, there was missing information 
on clinical measurements such as BMI and urea 
nitrogen. As the demographical characteristics 
were comparable between the patients with and 
without complete records, the findings would less 
likely to be removed by missing information. Sixth, 
although the current study used data from a large 
province in China, the observation was based on 
the relatively small number of patients each year 
specifically in the earlier years.
CONCLUSIONS
Peritoneal dialysis care increased rapidly in 
central region of China recently, where rural 
residents constituted the majority of population.
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